← All sarcoma trials
Recruiting now—Ages 18 Years to 90 Years

Effectiveness Of Radiofrequency Ablation And Stabilization In Metastatic Spine Lesions By Positron Emission Computed Tomography (PET-CT) Confirmation

Sponsor: National and Kapodistrian University of Athens · NCT06716294 on ClinicalTrials.gov ↗

Bring this to your care team →

Conditions studied

Bone Cancer MetastaticRadiofrequency AblationSpine MetastasesVertebral Metastasis

What it tests

  • Radiofrequency Ablation and Bone Augmentationdevice

Where it's running1 site

1 international site

  • 3rd Department of Radiology, NKUOA, General Hospital "LAIKON"

    Athens, Athens, Greece 11527

    Recruiting now
See the official eligibility language

Shown exactly as written on ClinicalTrials.gov. Your oncologist is the right person to judge whether it fits your situation.

Inclusion Criteria:

* only patients with secondary osteolytic and mixed (lytic and sclerotic) spine tumors with one to three active lesions will be enrolled.
* lesions to be treated must be metabolically active on PET-CT performed during the last month.
* Patients will be informed and sould sign an inform consent.
* post treatment patients should submittes a new PET-CT in order to verify the activity of the treated area.

Exclusion Criteria:

\-

Updated 2026-04-09 on ClinicalTrials.gov. Always confirm current details with the study team or your oncologist.